Kristin Rosengren is Vice President, Strategic Communications, at AcademyHealth, leading the organization’s public relations, marketing, membership and advocacy efforts. A member of AcademyHealth's leadership team, she guides the development of messaging and outreach to support the organization's mission, build relationships with members, partners and other stakeholders, and increase the awareness and perceived value of health services research. She also serves as co-director of the AcademyHealth Translation and Dissemination Institute, which seeks, tests and promotes new and innovative approaches to moving knowledge into action.
Ms. Rosengren has 20 years of experience in health care communications including strategic planning, media relations, crisis communications, message development and speaker training. Prior to joining AcademyHealth, Ms. Rosengren provided strategic communications counsel to clients in the health care and pharmaceutical industries as an Account Supervisor at Ketchum Public Relations in Washington, D.C., and as an Account Executive at McNeely, Pigott & Fox in Nashville, Tenn. Her clients have included health care providers, payers, voluntary health organizations and health technology companies.
She holds a bachelor’s degree in journalism and public relations from the University of Georgia.
Ms. Rosengren's areas of expertise include strategic communications, translation and dissemination, and public relations.
Why HSR?
"AcademyHealth’s mission calls us to work with our members to support the production and use of evidence. For me, that means answering the question of how we communicate evidence in ways that make it more likely to be understood and valued. How do we, collectively, continue to identify the right audiences, establish trust, and provide information that is timely and relevant to their questions? What are the implications for communicating evidence in highly polarized times? And how can we document and disseminate these lessons for the greatest benefit of our members? These are critical questions we’re exploring with our team, and through the Translation and Dissemination Institute."